Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Filings indexed 250 across all filing types
Latest filing 2025-02-12 Capital/Financing Update
Country KR South Korea
Listing KO 304840

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing from the Korean Exchange (KRX) system regarding the 'Adjustment of Conversion Price' (전환가액의 조정) for convertible bonds. This type of filing details changes to the capital structure, specifically the conversion price of debt instruments into equity, which falls under the category of capital and financing updates. It is not a report publication announcement, but a direct disclosure of a corporate action affecting the company's capital structure.
2025-02-12 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date for a shareholder meeting (the 24th Annual General Meeting). It is a standard corporate disclosure regarding shareholder rights and meeting preparation, which does not fit into the specific categories for full reports or financial results. As it is a regulatory notification of a corporate action, it falls under the general regulatory filing category.
2024-12-13 Korean
[기재정정]금전대여결정
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from the company 'PeopleBio' regarding a 'Decision on Lending Money' (금전대여결정). It is a formal disclosure of a financial transaction (lending to a subsidiary) and an amendment to a previous filing. Since it does not fit into specific categories like earnings, dividends, or M&A, and is a standard regulatory disclosure of corporate activity, it falls under the 'Regulatory Filings' category.
2024-11-22 Korean
분기보고서 (2024.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'PeopleBio' covering the period from January 1, 2024, to September 30, 2024. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2024
2024-11-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act (Article 147). It details changes in share ownership by major shareholders and their special relations (e.g., director resignation, share transfers, and market sales). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2024-11-12 Korean
반기보고서 (2024.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'PeopleBio' covering the period from January 1, 2024, to June 30, 2024. It contains detailed financial and operational information, including company history, capital structure, and business activities. As it is a comprehensive financial report for a period shorter than a full fiscal year (half-year) and contains substantive financial data and analysis, it is classified as an Interim/Quarterly Report. H1 2024
2024-08-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.